Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Metformin in pregnancy and lactation|
|Citation:||Australian Prescriber, 2007; 30(3):68-69|
|William M. Hague|
|Abstract:||Metformin improves insulin sensitivity and reduces hepatic glucose output in patients with diabetes. It offers potential benefits for pregnant women with gestational or type 2 diabetes because both conditions are associated with increased insulin resistance. Some cohort data are available and randomised trials are currently in progress to compare metformin with insulin, but strong evidence is not yet available to guide management. There are no long-term follow-up data to provide reassurance about the safety of metformin, given its passage across the placenta, although recent evidence suggests that there is no significant risk of teratogenesis. Limited amounts of metformin are transferred into breast milk, but the risk of neonatal hypoglycaemia is negligible.|
|Keywords:||birth defects; gestational diabetes; hypoglycaemic drugs; insulin|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.